Medicare Compliance & Reimbursement - 2003 Issue 10
LUNG-VOLUME REDUCTION: Study Suggests Who Gains From Disputed Surgery
Subscribe or sign in to view the full article.
Article Overview
This article reviews findings from a long-term clinical trial of lung-volume reduction surgery and discusses how the results may affect Medicare coverage policy. It focuses on which emphysema patients appeared to benefit most, the broader uncertainty surrounding the procedure, and why the study matters for clinicians, policymakers, and health services researchers evaluating evidence, outcomes, and costs.
Why This Topic Matters
The article is relevant because it connects clinical trial evidence to national coverage policy and highlights how subgroup outcomes and long-term uncertainty can influence decisions about expensive procedures.
What You Will Learn
- How a major study evaluated lung-volume reduction surgery over time
- Why subgroup findings matter in assessing treatment benefit
- How the article frames the relationship between clinical outcomes and cost-effectiveness
- What the study implies for coverage policy and future research needs
Who Should Read This
- Medical coders
- Compliance staff
- Health policy professionals
- Physicians
- Clinical researchers
- Healthcare administrators
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com